NCT05417867
Association Between Changes in the Gut Microbiome and Chemotherapy-Induced Nausea in Stage I-III Breast Cancer No drug interventions Not Available Not Available recruiting NCT04592198
Buccal Film Versus IV Injection Palonosetron for Moderately Emetogenic Chemotherapy Induced Nausea and Vomiting prevention 2 completed NCT05898880
The Effect of Acupressure on Pain, Nausea-Vomiting, and Mental Well-Being in Oncology Patients No drug interventions other Not Available not_yet_recruiting NCT01217190
Crossover Study Comparing Ondansetron Orally Dissolving Film Strip (ODFS) With Zofran Orally Disintegrating Tablets other 1 / 2 completed NCT05830279
Implementation of Personalized Medicine for Optimal Drug Therapy in Cancer No drug interventions Not Available Not Available recruiting NCT06080880
Ondanstron Weekly vs Every 3 Weeks for Prevention of Nausea and Vomiting Induced by Chemotherapy Combined With PD-1 Blockade prevention Not Available recruiting NCT04651608
The Effect of Acupressure Chemotherapy-related Nausea Vomiting in Children No drug interventions supportive_care Not Available completed NCT03008213
Combination of Netupitant and Palonosetron (Akynzeo®) in the Treatment of Refractory CINV supportive_care 2 terminated NCT01659775
Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in Chemotherapy-induced Nausea and Vomiting Associated With the Administration of Highly Emetogenic Chemotherapy (HEC) treatment 4 completed NCT01662687
Phase 4 Trial to Evaluate the Efficacy and Safety of Sancuso Patch in CINV (Chemotherapy-induced Nausea and Vomiting) Associated With the Administration of MEC (Moderately Emetogenic Chemotherapy) treatment 4 unknown_status NCT05244577
Olanzapine Combined With Fosaprepitant, Ondansetron, and Dexamethasone for Preventing Nausea and Vomiting in Patients With Testicular Cancer treatment 3 recruiting NCT01857232
Dose-finding Study of APD403 to Prevent Nausea and Vomiting After Chemotherapy prevention 2 completed NCT03204279
PK/PD Study of Netupitant and Palonosetron in Pediatric Patients for Prevention of Chemotherapy-induced Nausea and Vomiting prevention 2 completed NCT04472143
Granisetron Transdermal Patch for Prophylaxis of Nausea and Vomiting in Patients Receiving Oral Anticancer Agents treatment 2 unknown_status NCT04912271
Granisetron Transdermal Patch for Prophylaxis of Delayed CINV treatment 3 unknown_status NCT00619359
Evaluation of Fosaprepitant (MK0517) in Single Dose Schedule (0517-017) prevention 3 completed NCT05434663
Safety Study of Repeat Doses of SUSTOL in Adults prevention 4 active_not_recruiting NCT01111851
Aprepitant and Fosaprepitant Time-on-Target PET (Positron Emission Tomography) Study (0869-183) treatment 1 completed NCT01594749
Efficacy and Safety of Fosaprepitant Dimeglumine in Preventing Chemotherapy-Induced Nausea and Vomiting (MK-0517-031) prevention 3 completed NCT00952341
Aprepitant/MK0869 for Prevention of Chemotherapy Induced Nausea and Vomiting Associated With Cisplatin (0869-169)(COMPLETED) treatment 3 completed NCT05325190
Granisetron Transdermal Patch System for Prevention of CINV by CapeOX prevention 2 unknown_status NCT06017284
Thalidomide to Chemotherapy Related Nausea and Vomiting in Pancreatic Cancer treatment 3 recruiting NCT02478047
Comparative Effect Study Between Distal-proximal Point Association and Local Distribution Point Association in Chemotherapy-induced Nausea and Vomiting treatment Not Available unknown_status NCT00666783
An Efficacy and Safety Study of Palonosetron in Preventing Chemotherapy-Induced Nausea and Vomiting (CINV) in the Chinese Cancer Patients supportive_care 2 completed NCT04430361
the Efficacy and Safety of 5-HT3 Receptor Antagonist, Dexamethasone or Megestrol Acetate Dispersible Tablets in the Control of Nausea and Vomiting Induced by Highly Emetogenic Chemotherapy treatment 2 unknown_status NCT00891761
A Study of IV Casopitant for the Prevention of Nausea and Vomiting Caused By Cisplatin-Based Highly Emetogenic Chemotherapy supportive_care 3 withdrawn NCT05792228
A Standardized Intervention to Improve the Management of Chemotherapy-induced Nausea and Vomiting No drug interventions supportive_care Not Available completed NCT02484911
Aprepitant ,Olanzapine,Palonosetron and Dexamethasone for the Prevention of Chemotherapy-induced Nausea and Vomiting prevention 3 completed NCT03237611
Low Dose Aprepitant for Patients Receiving Carboplatin treatment 2 terminated NCT04054193
Safety of a Three-Day Fosaprepitant Regimen for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-045) prevention 4 completed NCT04085393
Granisetron Extended Release Injection (GERSC) for the Prevention of Chemotherapy-induced Nausea and Vomiting treatment 2 withdrawn NCT05311371
The Effect of Breathing Exercise on Chemotherapy-induced Nausea and Vomiting in With Autologous Hematopoietic Stem Cell Transplantation Patients No drug interventions prevention Not Available completed NCT01303978
Phase II Proof-of-concept Study of APD421 No drug interventions prevention 2 completed NCT00404378
Study Of Healthy Subjects To Assess The Effect Of Ketoconazole And The Way The Body Will React To Casopitant [GW679769] treatment 1 completed NCT02129478
Olanzapine for Prevention of Chemotherapy-induced Nausea and Vomiting in Children: A Multi-Centre Feasibility Study supportive_care 2 completed NCT02369107
The Effect of Acupuncture in Chemotherapy-induced Nausea and Vomiting No drug interventions treatment Not Available unknown_status NCT00460707
A Study to Assess the Safety and Interaction Between Casopitant and Ketoconazole When Taken By Healthy Adults treatment 1 completed NCT01937156
A Randomized Controlled Trial of SP-01 (Granisetron Transdermal Delivery System) in Chemotherapy-induced Nausea and Vomiting prevention 3 completed NCT04693832
The Effect of Using Interactive Mobile Application for the Management of Chemotherapy- Induced Nausea and Vomiting in Children No drug interventions supportive_care Not Available completed NCT01596400
Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 13 to 17 Years treatment 1 completed NCT05805800
Olanzapine and 5-HT3 With or Without Dexamethasone to Prevent CINV treatment 3 recruiting NCT02519842
Efficacy and Safety Study of Fosaprepitant (MK-0517) Plus Ondansetron Versus Ondansetron Alone for the Prevention of Chemotherapy-Induced Nausea and Vomiting in Pediatric Participants (MK-0517-044) prevention 3 terminated NCT01499849
Ph3 Safety/Efficacy Study of Rolapitant for the Prevention of CINV in Subjects Receiving Highly Emetogenic Chemotherapy prevention 3 completed NCT00431236
A Study of the Drug Casopitant for the Prevention of Nausea Caused By Cisplatin-Based Highly Emetogenic Chemotherapy prevention 3 completed NCT01596413
Pharmacokinetics and Safety of Sancuso and IV Granisetron in Pediatrics Aged 6 to 12 Years treatment 1 withdrawn NCT01500213
Ph3 Safety/Efficacy Study of Rolapitant for the Prevention of CINV in Subjects Receiving Highly Emetogenic Chemotherapy prevention 3 completed NCT05199818
Buccal Film vs IV Palonosetron for Prevention of CINV in Cancer Patients Receiving MEC prevention 3 unknown_status NCT03354741
Stimulation of Acupuncture Points by Athermic Laser Therapy for the Prevention of Chemotherapy Induced Nausea and Vomiting in Children No drug interventions other Not Available completed NCT04437017
Olanzapine or Dexamethasone, With 5-HT3 RA and NK-1 RA, to Prevent CINV treatment 3 completed NCT00366834
Intravenous And Oral Casopitant (GW679769) For The Prevention Of Chemotherapy Induced Nausea And Vomiting treatment 3 completed NCT01402024
Study to Evaluate Anti-emetic Effect of Aprepitant Versus Placebo in Children and Adolescent Receiving Chemotherapy prevention 3 completed NCT03405324
Effect of tDCS of the Motor Cortex on Chemotherapy Induced Nausia and Vomiting No drug interventions prevention Not Available unknown_status NCT03208816
Community-Led Action Research in Oncology: Improving Symptom Management No drug interventions supportive_care Not Available completed NCT01018758
Study With Palonosetron Alone in Preventing Chemotherapy-induced Nausea and Vomiting in Untreated Patients With Aggressive Non Hodgkin's Lymphomas Who Underwent Moderately Emetogenic Chemotherapy prevention 2 completed NCT02583139
Designed Music Narratives for the Reduction of Side Effects of Chemotherapy in Children (7-12 Years) With Cancer No drug interventions supportive_care Not Available unknown_status NCT06065722
Prevention of Breakthrough CINV in Patients Receiving Moderately or Highly Emetogenic Chemotherapy supportive_care 2 recruiting NCT02390648
Efficacy of Ginger as an Adjunctive Prophylaxis for Chemotherapy-induced Nausea and Vomiting No drug interventions supportive_care 2 completed NCT03571126
Olanzapine for the Prevention and Treatment of Nausea and Vomiting Induced by Chemotherapy of Lung Cancer treatment 4 unknown_status NCT02382666
A Phase 1, 2-Part, Single Ascending Dose Assessment of the Safety, Tolerability, and Pharmacokinetics of Rolapitant Intravenous in Healthy Volunteers prevention 1 completed NCT00787566
Phase 2 Study of Efficacy, Tolerability, and Safety of Intranasal Granisetron for Chemo-Induced Nausea and Vomiting prevention 2 completed NCT06331520
NEPA Combined With Olanzapine, Dexamethasone-sparing for the Effect of CINV in Patients Receiving HEC Regimens prevention 3 not_yet_recruiting NCT00337727
Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)(0869-130)(COMPLETED) prevention 3 completed NCT05512676
Trabectedin/Caelyx vs Cisplatin Hypersensitivity in Relapsed Ovarian Cancer Patients Allergic to Platinum No drug interventions Not Available Not Available completed NCT01442376
Efficacy and Safety of Palonosetron Intravenous in Prevention of Chemotherapy Induced Nausea and Vomiting in Pediatric Patients prevention 3 completed NCT05319860
Aromatherapy for Chemotherapy-induced Nausea and Vomiting (CINV) No drug interventions supportive_care 2 completed NCT01339260
An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting prevention 3 completed NCT01490060
Fosaprepitant in Patients Receiving Ifosfamide-based Regimen treatment Not Available completed NCT02106494
A Prospective, Multicenter, Study of APF530 (Granisetron) SC for Prevention of CINV in Patients Receiving HEC treatment 3 completed NCT00086762
Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors No drug interventions other Not Available completed NCT04342780
Prevalence of Delayed Chemotherapy Associated Nausea No drug interventions Not Available Not Available completed NCT00437229
A Study to Assess the Safety & Interaction Between GW679769, Dexamethasone, & Ondansetron When Taken by Healthy Adults prevention 1 completed NCT01346267
Acupressure in Controlling Nausea in Young Patients Receiving Highly Emetogenic Chemotherapy No drug interventions supportive_care Not Available completed NCT00211601
Study of Chemotherapy and Patient Health Outcomes for Nausea and Emesis (0000-041) No drug interventions Not Available Not Available completed NCT00601172
A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting. supportive_care 3 completed NCT04918069
Capsaicin to Prevent Delayed Chemotherapy Induced Nausea and Vomiting (CapCIN) prevention 2 completed NCT00334646
Cyclophosphamide Drug Interaction Study In Cancer Patients treatment 1 terminated NCT01757210
A Study to Evaluate the Safety and Efficacy of Aprepitant (MK0869) for Chemotherapy-Induced Nausea and Vomiting in Pediatric Patients No drug interventions Not Available Not Available completed NCT04785495
Prevalence of Anticipatory Nausea and Vomiting in Cancer Patients Exposed to Highly Emetogenic Chemotherapy No drug interventions Not Available Not Available unknown_status NCT00972595
Bioequivalence of Two Formulations of Ondansetron in Healthy Adults (0869-106) treatment 1 completed NCT06121414
Effectiveness of Laserpuncture and Standard Antiemetic on RINVR Scores in Adolescent Patients Undergoing Chemotherapy No drug interventions treatment Not Available completed NCT04150614
BMT-08: A Comparative Effectiveness Study of Transdermal Granisetron to Ondansetron supportive_care 4 recruiting NCT03984214
Efficacy and Safety of Dronabinol in the Improvement of Chemotherapy-induced and Tumor-related Symptoms in Advanced Pancreatic Cancer treatment 3 active_not_recruiting NCT02097823
Pilot Study of Olanzapine and Aprepitant to Prevent Nausea and Vomiting in Children Receiving Chemotherapy supportive_care 2 completed NCT00511823
The Pharmacokinetic Interaction Between Oral Casopitant and Oral Dolasetron, Granisetron or Rosiglitazone in Subjects treatment 1 completed NCT01370408
Palonosetron, Ondansetron, and Dexamethasone for Delayed Nausea and Vomiting in Autologous Transplant Patients prevention 2 completed NCT05838638
Serious Gaming for Chemotherapy-induced Nausea and Vomiting No drug interventions supportive_care Not Available recruiting NCT00104403
Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy treatment 2 completed NCT02205164
Palonosetron Plus Aprepitant Versus Palonosetron in Preventing Nausea and Vomiting in Leukemic Patients supportive_care 2 unknown_status NCT06120764
Effect of Guided Imagery on Chemotherapy-related Nausea and Vomiting No drug interventions prevention Not Available recruiting NCT02517021
A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting prevention 3 completed NCT00945321
A Study to Assess the Bioequivalence of Aprepitant and Fosaprepitant and the Effect of Food on Aprepitant Bioavailability (0869-165) treatment 1 completed NCT02195921
Acupuncture for Chemotherapy-Induced Nausea and Vomiting No drug interventions treatment Not Available completed NCT00990821
A Study to Investigate the Safety and Tolerability of MK-0517 in Healthy Subjects (MK-0517-012) treatment 1 completed NCT04873284
Comparative Study of Fosaprepitant and Aprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting in Pediatric Caner Patients treatment Not Available unknown_status NCT01363479
An Efficacy and Safety Study of Oral and Intravenous Palonosetron for the Prevention of Nausea and Vomiting prevention 3 completed NCT01697579
Study of the Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Fosaprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Children (MK-0517-029) treatment 2 completed NCT00971633
A Bioequivalence Study of 3 Formulations of Ondansetron in Healthy Adults (0869-095)(COMPLETED) treatment 1 completed NCT05143554
Auricular Neurostimulation for Chemotherapy Induced Nausea and Vomiting No drug interventions prevention Not Available recruiting NCT03948477
Pantoprazole Prophylaxis Against Delayed CINV for Patients Receiving Breast Cancer Chemotherapy prevention 2 completed NCT02285647
An Open-Label, Randomized, Pivotal, Bioequivalence Study of Oral and Intravenous Rolapitant prevention 1 completed NCT01031498
Palonosetron Versus Ondansetron for the Prevention of Nausea and Vomiting supportive_care 2 completed NCT03478605
Trial to Evaluate Efficacy of Olanzapine With Short-acting 5HT3 Inhibitors in Chemotherapy-induced Nausea & Vomiting (CINV) Prophylaxis treatment 2 unknown_status NCT01376297
A Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting prevention 3 completed NCT02434861
An Open Label, Single Dose, Three Part Study to Assess the Effects of Rolapitant (2 mg/mL IV Solution) on the Pharmacokinetics of Digoxin; Sulfasalazine; and the Cooperstown Cocktail (Midazolam, Omeprazole, Warfarin, Caffeine, and Dextromethorphan in Healthy Subjects basic_science 1 completed NCT00440128
The Effects Of GW679769 (Casopitant) On The Pharmacokinetics Of Docetaxel In Subjects With Cancer treatment 1 completed NCT03601871
The Efficacy and Safety of Thalidomide in Preventing CINV Induced by Cisplatin-containing Chemotherapy prevention Not Available unknown_status NCT02909478
Aprepitant Without Steroid in Preventing Chemotherapy-induced Nausea and Vomiting in Patients With Colorectal Cancer supportive_care 3 completed NCT01449188
To Investigate the Effect of Intravenous Ondansetron on Cardiac Conduction as Compared to Placebo and Moxifloxacin in Healthy Adult Subjects other 1 completed NCT02842307
Acupuncture for Chemical Therapy Induced Nausea and Vomiting No drug interventions treatment Not Available completed NCT05251337
Use of Aromatherapy to Reduce Symptom Burden No drug interventions supportive_care 2 completed NCT00553059
Palonosetron and Dexamethasone With or Without Dronabinol in Preventing Nausea and Vomiting in Patients Receiving Chemotherapy For Cancer supportive_care 3 completed NCT00818259
A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134) treatment 1 terminated NCT02933099
Aprepitant for the Prevention of Chemotherapy-induced Nausea and Vomiting supportive_care 3 unknown_status NCT05841849
Efficacy and Safety of Intravenous Versus Oral 5-HT3 Antagonists Combined With NK-1 Receptor Antagonists for the Prevention of CINV in Breast Cancer prevention 4 not_yet_recruiting NCT01012336
Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/Carboplatin treatment 2 completed NCT03245918
Relative Bioavailability of an Extemporaneous Oral Suspension of Aprepitant in Healthy Adult Volunteers supportive_care 1 completed NCT01581918
Efficacy and Safety Evaluation of Carbamazepine for Prevention of Chemotherapy-induced Nausea and Vomiting prevention 2 unknown_status NCT01874119
Fosaprepitant for N/V With High-dose Interleukin-2 for Metastatic Melanoma and Renal Cell Carcinoma treatment 2 terminated NCT04535141
Olanzapine for Nausea/Vomiting Prophylaxis in Recipients of Hematopoietic Stem Cell Transplants supportive_care 3 completed NCT01387841
Effect of Yoga in Reducing Chemotherapy Induced Nausea and Vomiting No drug interventions supportive_care 2 completed NCT03232541
The Effects of Acupuncture and the Therapist´s Communication on Chemotherapy Induced Nausea and Vomiting No drug interventions supportive_care Not Available recruiting NCT01736917
Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors treatment 2 completed NCT03061396
The Comparative Study on the Efficacy and Safety of Single Acupoint and Matching Acupoints No drug interventions treatment Not Available unknown_status NCT02557035
An Efficacy and Safety Study of Intravenous Palonosetron Administered as an Infusion and as a Bolus for the Prevention of Nausea and Vomiting prevention 3 completed NCT03996863
Prevention of Unmitigated Chemotherapy-induced Emesis No drug interventions treatment Not Available withdrawn NCT05564286
Triple Antiemetic Regimen for Chemoradiotherapy in Cervical Cancer or Nasopharyngeal Cancer prevention 3 completed NCT03668639
Safety and Antiemetic Efficacy of Akynzeo Plus Dexamethasone During Radiotherapy and Concomitant Weekly Cisplatin supportive_care 2 / 3 unknown_status NCT05851625
Efficacy of Ear Acupuncture in Preventing Chemotherapy Induced Nausea and Vomiting in Cancer Patients No drug interventions prevention Not Available completed NCT03649230
Observational Study on the Use of Akynzeo® in Patients Receiving HEC Not Available Not Available completed NCT01362530
A Study of the Safety and Efficacy of Aprepitant for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Pediatric Participants (MK-0869-208) prevention 3 completed NCT01596426
Safety and Pharmacokinetics of Sancuso and IV Granisetron in Patients Aged 2 to 5 Years treatment 1 withdrawn NCT01500226
Ph 3 Safety/Efficacy Study of Rolapitant for Prevention of CINV in Subjects Receiving Moderately Emetogenic Chemotherapy prevention 3 completed NCT05885126
The Effect of Mandala Technique on Acute Nausea-vomiting and Comfort Level in Cancer Patients No drug interventions prevention Not Available enrolling_by_invitation NCT05242874
Fosaprepitant , Tropisetron and Olanzapine for the Prevention of Nausea and Vomiting in Patients With Breast Cancer treatment 3 completed NCT00404274
A Study Testing the Effect and Safety of Casopitant (GW679769) While Taking Warfarin in Healthy Human Volunteers prevention 1 completed NCT05346731
Low Dose Olanzapine to the Prophylaxis of Nausea and Vomiting Induced by Chemotherapy in Children and Adolescents treatment 3 unknown_status NCT01481831
Efficacy and Safety of Palonosetron Hydrochloride in the Prevention of Nausea and Vomiting treatment 4 completed NCT03674294
Aprepitant Triple Therapy for the Prevention of CINV in Nondrinking and Young Women Who Received Moderately Emetogenic Chemotherapy prevention 3 completed NCT00405080
A Study in Healthy Subjects to Assess How Dosing of Rifampin Affects What the Body Does to a Dose of GW679769 (Casopitant). treatment 1 completed NCT03143829
Promoting Cancer Symptom Management in Older Adults No drug interventions supportive_care Not Available completed NCT04817189
Oral Akynzeo® vs Standard of Care in Preventing CINV in High-risk MEC Patients (MyRisk) supportive_care 4 active_not_recruiting NCT03862144
NEPA to Prevent Chemotherapy Induced Nausea and Vomiting in Patients With Breast Cancer prevention 2 completed NCT00359567
Comparative Study of Palonosetron With Granisetron as a Control in Patients Receiving Highly Emetogenic Chemotherapy treatment 3 completed NCT03740672
Adherence to the Antiemesis National Comprehensive Cancer Network (NCCN) Guideline No drug interventions Not Available Not Available unknown_status NCT02445872
Safety and Efficacy of Aprepitant for CINV in Patients With Lung Cancer Receiving Multiple-day Cisplatin Chemotherapy supportive_care 2 unknown_status NCT00273468
To Study the Safety and Effectiveness of a Granisetron Patch to Treat Chemotherapy-Induced Nausea and Vomiting (CINV) treatment 3 completed NCT04201769
Dexamethasone-sparing Approach Including NEPA Against Emesis Caused by Cisplatin supportive_care 3 unknown_status NCT03403712
A Study to Assess the Safety and the Efficacy of IV Fosnetupitant/Palonosetron (260 mg/0.25 mg) Combination Compared to Oral Netupitant/Palonosetron (300 mg/0.5 mg) Combination for the Prevention of CINV in AC Chemotherapy in Women With Breast Cancer prevention 3 completed NCT00642512
Dronabinol Versus Standard Ondansetron Antiemetic Therapy in Preventing Delayed-Onset Chemotherapy-Induced Nausea and Vomiting prevention 3 completed NCT03219710
"Olanzapine for Prevention of Chemotherapy Induced Nausea and Vomiting in Children and Adolescents Receiving Highly Emetogenic Chemotherapy (HEC)" supportive_care 3 completed NCT01993381
Evaluation of Predictive Risk Factors of Chemotherapy-induced Nausea and Vomiting No drug interventions Not Available Not Available unknown_status NCT04075955
Feasibility of Olanzapine at REduced doSe in hIGHly Emetogenic chemoTherapy prevention 3 completed NCT02127255
Acupuncture for Chemical Therapy Induced Nausea and Vomiting: a Cross-over Trail No drug interventions treatment Not Available completed NCT01074255
Re-examination Study of EMEND (Aprepitant) (MK-0869-184) Not Available Not Available completed NCT05590923
Steroid-sparing Therapy (Olanzapine) Versus Dexamethasone-based Therapy for Chemotherapy-induced Nausea and Vomiting prevention 4 recruiting NCT02970643
Proof-of-Concept Trial of Palonosetron and Olanzapine Without Dexamethasone for the Prevention of CIN prevention Not Available unknown_status